Financials
- Market Capitalization 29.12 B
- Employee 7 500
- Founded 1978
- CEO Chris Viehbacher
- Website www.biogen.com
- Headquarter Delaware, United States
- FIGI BBG000C17X76
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 145 | SNY Sanofi - American Depositary Shares | 43.68 USD | +1.16% | +0.88% | +0.78% | -9.19% | 106.53 B USD | ||
| 408 | ONC BeOne Medicines Ltd - American Depositary Shares | 311.26 USD | +1.53% | +3.58% | +18.46% | -1.41% | 34.60 B USD | ||
| 1179 | CGON CG Oncology, Inc. - Common stock | 73.00 USD | +1.71% | +4.11% | +20.26% | +67.58% | 6.44 B USD | ||
| 1311 | ORKA Oruka Therapeutics, Inc. - Common Stock | 86.65 USD | -0.94% | +1.06% | +26.68% | +170.19% | 5.23 B USD |
Frequently asked questions about Biogen Inc. - Common Stock
What is the Biogen Inc. - Common Stock stock price today?
The current price of Biogen Inc. - Common Stock (BIIB) is 197.24. Over the past 24 hours, the stock has changed by +2.76%. Follow the BIIB chart for real-time price dynamics.
What is the stock ticker of Biogen Inc. - Common Stock?
Biogen Inc. - Common Stock trades under the ticker BIIB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Biogen Inc. - Common Stock stock going up?
BIIB has changed by -0.84% over the last week, +1.08% over the last month, and +53.88% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Biogen Inc. - Common Stock net income for the last quarter?
Biogen Inc. - Common Stock reported net income of 319.5 M for the last quarter. The previous quarter showed -48.9 M, which means net income changed by +753.37%.
How many employees does Biogen Inc. - Common Stock have?
As of the latest available data, Biogen Inc. - Common Stock has 7 500 employees. Workforce size can provide additional context about the company's scale and operations.
What is Biogen Inc. - Common Stock EBITDA?
Biogen Inc. - Common Stock EBITDA is 582.1 M, and its EBITDA margin is 23.49%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Biogen Inc. - Common Stock stock?
You can buy Biogen Inc. - Common Stock (BIIB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Biogen Inc. - Common Stock stock?
Investing in Biogen Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BIIB chart and related analysis on metatrader.com as part of your research.